Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famitinib in Gastroenteropancreatic Neuroendocrine Tumors
CTR20131980Phase 2Active
- Sponsor
- Hengrui Therapeutics
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of famitinib in Gastroenteropancreatic Carcinoid Tumor, sponsored by Hengrui Therapeutics. Started Jan 2014; status: active.
02
Drugs
famitinib
03
Conditions
Gastroenteropancreatic Carcinoid Tumor
Beyond the preview
Go deeper on CTR20131980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131980.